ArticleFrontiers in immunology2025

Case Report: Complete response to four cycles of camrelizumab in a PD-L1 negative patient with advanced oral squamous cancer.

Jianqiao He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.